IGG4 RELATED DISEASE
Clinical trials for IGG4 RELATED DISEASE explained in plain language.
Never miss a new study
Get alerted when new IGG4 RELATED DISEASE trials appear
Sign up with your email to follow new studies for IGG4 RELATED DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy aims to tame rebellious immune system in chronic disease
Disease control Recruiting nowThis study is testing a new cell therapy for adults with IgG4-related disease, a chronic condition where the immune system attacks the body's own tissues. The therapy involves collecting a patient's own immune cells, modifying them in a lab to better target the disease, and then …
Matched conditions: IGG4 RELATED DISEASE
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Apr 01, 2026 23:11 UTC
-
New drug combo trial aims to tame mysterious autoimmune disease
Disease control Recruiting nowThis study is testing if adding a medication called lenalidomide to the standard steroid treatment works better for people with active IgG4-Related Disease (IgG4-RD). It will involve about 200 adults to see if the combination lowers the chance of the disease flaring up again over…
Matched conditions: IGG4 RELATED DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New drug tested for rare swelling disease
Disease control Recruiting nowThis study is testing if a drug called efgartigimod can reduce swelling in the tear glands, salivary glands, or pancreas in adults with IgG4-related disease. Up to 5 participants will receive weekly injections for 12 weeks and have regular checkups and scans. The goal is to see i…
Matched conditions: IGG4 RELATED DISEASE
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Donor cells tested to fight mysterious autoimmune disease
Disease control Recruiting nowThis early-stage study is testing a new cell therapy called ACE1831 for people with active IgG4-Related Disease (IgG4-RD), a condition where the immune system attacks the body's own tissues. The therapy uses immune cells (gamma delta T cells) from healthy donors. Researchers will…
Matched conditions: IGG4 RELATED DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Acepodia Biotech, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC